http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_bfab8e78f5b95131f490cdaa9b1e3cd8
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Sjöstrand |
| name | Mikaela Sjöstrand |
| given-name | Mikaela |
| organization-name | Late Stage Development, Cardiovascular, Renal and Metabolism BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden BioPharmaceuticals R&D, AstraZeneca Gothenburg Sweden Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca Gothenburg Sweden Division of Research and Development (E.N., H.E., M.L.-Z., M.S.), AstraZeneca, 431 83 Mölndal, Sweden AstraZeneca Gothenburg Sweden Lundberg Laboratory for Diabetes Research and the Wallenberg Laboratory, Department of Internal Medicine and Heart and Lung Diseases, Sahlgrenska University Hospital, Gothenburg University, S-413 45 Gothenburg, Sweden for the DAPA-HF Investigators and Committees AstraZeneca, Gothenburg, Sweden (O.B., M.S., A.M.L.). Late Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (O.B., D.L., A.N., M.S., A.M.L.). Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (O.B., M. Söjstrand, A.M.L.). Late Stage Development, Cardiovascular, Renal and Metabolism BioPharmaceuticals R&D, AstraZeneca Gothenburg Sweden Lat , Gothenburg, Sweden; e Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca , Gothenburg, Sweden Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (O.B., D.L., A.M.L., M.Sjöstrand) Lundberg Laboratory for Diabetes Research and AstraZeneca R&D , Gothenburg, Sweden Late Stage Development, Cardiovascular, Renal and Metabolism Biopharmaceuticals R&D, Astrazeneca Gothenburg Sweden Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca , Gothenburg, Pepparedsleden 1, Mölndal 431 83, Sweden Late Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden Late Stage Development, Cardiovascular, Renal, and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (O.B., P.J., A.M.L., D.L., M.S.). Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D AstraZeneca Gothenburg Sweden Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (O.B., A.M.L., M. Sjöstrand). AstraZeneca R&D Gothenburg Sweden Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden (S.B.G., O.B., A.-M.L., M.S.). Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden Late Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D (O.B., A.M.L., D.L., M.S.), AstraZeneca, Gothenburg, Sweden. AstraZeneca R&D, Gothenburg, Sweden |
Incoming Links
Total number of triples: 74.